Brief: Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial
01/10/2025 14:50
Oct 1 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026 Source text: ID:nBw6Vz6B6a Further company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical To Reduce Workforce By 25 Of 43 Employees Effective Sept 23, 2026 - SEC Filing
Brief: Adagio Medical Announces Strategic Review Process To Maximize Shareholder Value
Adagio Medical Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Adagio Medical Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Adagio Medical Reports Second Quarter 2026 Results